Aptus Pharma opened higher at ₹486.00, compared with its previous close of ₹480.00. In the last trading session on 12 Nov 2026, the stock traded between ₹486.00 and ₹488.40, with an average traded price of ₹487.06. It showed an upward intraday trend.
An investment of ₹10,000 made 2 years ago in Aptus Pharma is now worth
₹ 1,43,783.00
Giving a profit of
₹ 1,33,783.00 (1337.83%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+8.00 (+1.67%)
Day High
₹488.40
Day Low
₹486.00
Day Open
₹486.00
Prev Close
₹480.00
Volume
2,400
Value Traded
₹0.12 Cr
1W Return
4.61%
1M Return
15.80%
3M Return
81.55%
6M Return
183.46%
1Y Return
660.84%
Market Cap (₹ Cr.)
837
PE Ratio
-
PB Ratio
35.26
Dividend Yield
-
ROE
19.79%
ROCE
29.60%
Book Value (₹)
13.61
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
4.61%
6 Weeks
-
1 Month
15.80%
3 Months
81.55%
9 Months
425.07%
No data available.
Aptus Pharma board to consider preferential share allotment on Nov 12
Board meeting scheduled for November 12, 2026, to approve preferential allotment. Issue comprises 15,99,270 equity shares at a minimum price of ₹280 per share. Allotment follows BSE in-principle approval received on October 30, 2026.
6 days agoAptus Pharma H1FY27 Results: Net profit rises 190% YoY to ₹5.07 crore
Net profit rose 190% YoY to ₹5.07 crore in H1FY27. Revenue from operations tripled to ₹48.92 crore. Trade receivables increased to ₹28.64 crore, impacting cash flow. Manufacturing expansion planned with ₹35 crore CAPEX, ₹25 crore via preferential issue. Geographic coverage target set at 46% of India by March 2027.
14 days agoAptus Pharma closes trading window ahead of Q2FY27 results
Trading window closed from October 1, 2026. Window reopens 48 hours after Q2FY27 results declaration. Closure applies to half year ended September 30, 2026. Notice filed with BSE on September 28, 2026.
1mo agoAptus Pharma to host virtual investor meet on Sep 25
Aptus Pharma to host virtual investor meet on Sep 25. Session part of Arihant Capital Bharat Connect conference. Management interaction scheduled from 3:00 pm to 4:00 pm. Intimation filed under Regulation 30 of Listing Regulations.
1mo agoAptus Pharma shareholders unanimously approve preferential allotment at 16th AGM
Shareholders unanimously approved all three resolutions at the 16th AGM with 100% assent. Special resolution for preferential allotment of equity shares passed without dissent. Promoter group voted in favour with 1,25,00,000 shares; public non-institutions with 14,38,000 shares. Total of 130 members participated via remote e-voting, representing 1,39,38,000 votes. Statutory and secretarial audit reports contained no qualifications or adverse remarks.
1mo agoAptus Pharma to host investor analyst meet on Sep 18 in Mumbai
Aptus Pharma hosts investor meet on September 18, 2026. Session runs from 4:00 pm to 6:00 pm in Mumbai. Disclosures made under SEBI LODR Regulation 30 (6). Discussions limited to publicly available information.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹4,862.00 | -1.22% | ₹4,31,641.63 | 61.80 | +26.25% | |
| ₹2,512.10 | -0.96% | ₹2,40,960.08 | 49.40 | -9.30% | |
| ₹1,742.30 | +0.78% | ₹1,18,262.51 | 61.00 | +5.13% | |
| ₹12,890.00 | -0.79% | ₹78,848.89 | 45.50 | -15.79% | |
| ₹1,162.00 | -0.95% | ₹72,922.66 | 44.20 | -20.30% | |
| ₹705.00 | -0.83% | ₹72,808.94 | 45.80 | +38.57% | |
| ₹477.00 | -0.51% | ₹55,618.33 | 45.50 | -14.84% | |
| ₹1,139.70 | +2.24% | ₹37,710.93 | 80.20 | -14.80% | |
| ₹1,618.20 | +2.26% | ₹33,272.58 | 60.70 | -10.00% | |
| ₹6,677.00 | +7.54% | ₹23,548.29 | 177.40 | -7.32% | |
| ₹838.20 | +0.26% | ₹22,850.30 | 54.20 | -25.39% | |
| ₹350.05 | -4.81% | ₹19,592.64 | 21.40 | +74.15% |
An investment of ₹10,000 made 2 years ago in Aptus Pharma is now worth
₹ 1,43,783.00
Giving a profit of
₹ 1,33,783.00 (1337.83%)
Note: Past profits do not guarantee future returns.
